BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $1.64 and last traded at $1.62, with a volume of 5515 shares. The stock had previously closed at $1.58.
BioRestorative Therapies Trading Up 2.5 %
The company has a market cap of $2.66 billion, a P/E ratio of -1.48 and a beta of 102.36. The business’s 50 day simple moving average is $1.66 and its 200 day simple moving average is $1.57.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- What is a buyback in stocks? A comprehensive guide for investors
- Texas Roadhouse Stock Steering for New Highs This Year
- The 3 Best Retail Stocks to Shop for in August
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Short Selling: How to Short a Stock
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
